| Product Code: ETC7626955 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Communicable Diseases Treatment Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Communicable Diseases Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Communicable Diseases Treatment Market - Industry Life Cycle |
3.4 Ireland Communicable Diseases Treatment Market - Porter's Five Forces |
3.5 Ireland Communicable Diseases Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Ireland Communicable Diseases Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Ireland Communicable Diseases Treatment Market Revenues & Volume Share, By Infectious Agent, 2021 & 2031F |
3.8 Ireland Communicable Diseases Treatment Market Revenues & Volume Share, By Mode of Transmission, 2021 & 2031F |
3.9 Ireland Communicable Diseases Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 Ireland Communicable Diseases Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Ireland Communicable Diseases Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of communicable diseases in Ireland |
4.2.2 Technological advancements in treatment options |
4.2.3 Rising public health awareness and government initiatives to combat diseases |
4.3 Market Restraints |
4.3.1 High treatment costs and healthcare expenditure |
4.3.2 Limited access to healthcare services in rural areas |
4.3.3 Regulatory challenges and compliance requirements |
5 Ireland Communicable Diseases Treatment Market Trends |
6 Ireland Communicable Diseases Treatment Market, By Types |
6.1 Ireland Communicable Diseases Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Gastroenteritis, 2021- 2031F |
6.1.4 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Gonorrhoea, 2021- 2031F |
6.1.5 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Whooping Cough, 2021- 2031F |
6.1.6 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Common Cold, 2021- 2031F |
6.1.7 Ireland Communicable Diseases Treatment Market Revenues & Volume, By HIV/AIDS, 2021- 2031F |
6.1.8 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Pink Eye, 2021- 2031F |
6.1.9 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Communicable Diseases Treatment Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.3 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2.4 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.2.5 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Antivirals, 2021- 2031F |
6.2.6 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.2.7 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Antiparasitics, 2021- 2031F |
6.2.8 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Communicable Diseases Treatment Market, By Infectious Agent |
6.3.1 Overview and Analysis |
6.3.2 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Bacteria, 2021- 2031F |
6.3.3 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Viruses, 2021- 2031F |
6.3.4 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Fungi/Parasites, 2021- 2031F |
6.4 Ireland Communicable Diseases Treatment Market, By Mode of Transmission |
6.4.1 Overview and Analysis |
6.4.2 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Direct Contact, 2021- 2031F |
6.4.3 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Person-to-person Contact, 2021- 2031F |
6.4.4 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Droplet Spread, 2021- 2031F |
6.4.5 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4.6 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Indirect Contact, 2021- 2031F |
6.4.7 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Airborne Transmission, 2021- 2031F |
6.4.8 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.4.9 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.5 Ireland Communicable Diseases Treatment Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Sexually Transmitted Diseases, 2021- 2031F |
6.5.3 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Helminthic Diseases, 2021- 2031F |
6.5.4 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Contact Communicable Diseases, 2021- 2031F |
6.5.5 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Oral Contamination Diseases, 2021- 2031F |
6.5.6 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Air Borne Diseases, 2021- 2031F |
6.6 Ireland Communicable Diseases Treatment Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 Ireland Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Communicable Diseases Treatment Market Import-Export Trade Statistics |
7.1 Ireland Communicable Diseases Treatment Market Export to Major Countries |
7.2 Ireland Communicable Diseases Treatment Market Imports from Major Countries |
8 Ireland Communicable Diseases Treatment Market Key Performance Indicators |
8.1 Number of patients receiving treatment for communicable diseases |
8.2 Success rate of treatment options |
8.3 Adoption rate of new technologies in disease treatment |
8.4 Percentage of population covered by government healthcare initiatives |
8.5 Rate of disease prevention programs implemented |
9 Ireland Communicable Diseases Treatment Market - Opportunity Assessment |
9.1 Ireland Communicable Diseases Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Ireland Communicable Diseases Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Ireland Communicable Diseases Treatment Market Opportunity Assessment, By Infectious Agent, 2021 & 2031F |
9.4 Ireland Communicable Diseases Treatment Market Opportunity Assessment, By Mode of Transmission, 2021 & 2031F |
9.5 Ireland Communicable Diseases Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 Ireland Communicable Diseases Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Ireland Communicable Diseases Treatment Market - Competitive Landscape |
10.1 Ireland Communicable Diseases Treatment Market Revenue Share, By Companies, 2024 |
10.2 Ireland Communicable Diseases Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here